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Table S2: Characteristics of non-Kp BSI isolate genomes 
 K. quasipneumoniae subsp. 
quasipneumoniae 
K. quasipneumoniae subsp. 
similipneumoniae 
K. variicola 
N 5 20 9 



















# K loci 3 15 9 
Common  
K locia 





# O types 2 4 4 
Common  
O typesa 





% ESBL+ 0 65% 0 






% Carb+ 20% 0 0 
Virulence 
determinants 
- ICEKp3 + iuc1 + iro1 + 
rmpA + peg-344 
(n=1 ST367 from Vietnam) 
ybt plasmid lineage 
(n=1 ST209-1LV from 
Cambodia) 
a Only O types detected in >1 genome are shown. 
 
  
Table S3: K locus prevalence among K. pneumoniae sensu stricto. 
 K locus Prevalence (%) 
Cambodia Hong Kong India Laos Nepal Vietnam Mean  ESBL+ Carb+ 
1 KL2 12 11 2 11 6 10 9 3 0 
2 KL1 2 7 2 16 0 19 8 2 0 
3 KL24 5 7 1 23 0 1 6 11 2 
4 KL51 0 0 22 2 3 3 5 11 23 
5 KL62 7 11 5 0 0 5 5 4 4 
6 KL112 0 0 2 0 22 0 4 6 11 
7 KL57 0 7 2 7 0 6 4 1 0 
8 KL10 5 0 1 7 3 5 3 6 0 
9 KL23 7 4 0 2 3 4 3 2 0 
10 KL13 2 0 0 0 16 0 3 3 0 
11 KL64 0 0 18 0 0 0 3 3 21 
12 KL102 7 4 0 3 0 3 3 2 0 
13 KL117 0 7 4 0 3 0 2 2 4 
14 KL54 2 7 1 2 0 1 2 1 0 
15 KL122 10 0 0 0 0 1 2 3 0 
16 KL105 0 0 0 0 9 1 2 2 5 
17 KL3 0 4 0 2 3 1 2 3 0 
18 KL149 0 4 1 0 0 3 1 1 2 
19 KL19 0 0 4 0 0 4 1 3 2 
20 KL52 2 0 0 2 3 0 1 1 0 
21 KL39 0 4 0 0 3 0 1 1 0 
22 KL7 5 0 0 2 0 0 1 1 0 
23 KL17 2 0 2 2 0 0 1 1 4 
24 KL5 0 4 0 0 0 3 1 0 0 
25 KL25 5 0 0 0 0 1 1 1 0 
26 KL28 5 0 0 0 0 1 1 2 0 
27 KL27 2 0 0 0 3 0 1 1 0 
28 KL125 0 4 0 2 0 0 1 0 0 
29 KL21 2 0 0 2 0 1 1 1 0 
30 KL103 0 4 0 0 0 1 1 1 0 
31 KL12 0 4 0 0 0 1 1 1 0 
32 KL20 0 0 1 0 0 4 1 0 0 
33 KL9 0 4 1 0 0 0 1 0 0 
34 KL107 0 0 0 0 3 1 1 1 0 
35 KL45 0 0 0 2 0 3 1 1 2 
36 KL15 2 0 0 2 0 0 1 2 0 
37 KL114 0 4 0 0 0 0 1 0 0 
38 KL106 0 0 0 3 0 0 1 1 0 
39 KL148 0 0 0 3 0 0 1 1 0 
40 KL162 0 0 0 0 0 3 0 0 0 
41 KL163 0 0 0 0 0 3 0 1 2 
42 KL31 0 0 1 0 0 1 0 0 2 
43 KL34 2 0 0 0 0 0 0 0 0 
44 KL111 2 0 0 0 0 0 0 0 0 
45 KL135 2 0 0 0 0 0 0 1 0 
46 KL157 2 0 0 0 0 0 0 1 0 
47 KL35 2 0 0 0 0 0 0 0 0 
48 KL8 2 0 0 0 0 0 0 1 0 
49 KL128 0 0 0 2 0 0 0 0 0 
50 KL136 0 0 0 2 0 0 0 1 0 
51 KL30 0 0 0 2 0 0 0 1 2 
52 KL56 0 0 0 2 0 0 0 0 0 
53 KL63 0 0 0 2 0 0 0 0 0 
54 KL142 0 0 0 0 0 1 0 1 0 
55 KL127 0 0 0 0 0 1 0 0 0 
56 KL164 0 0 0 0 0 1 0 0 0 
57 KL22 0 0 0 0 0 1 0 0 0 
58 KL42 0 0 0 0 0 1 0 0 0 
59 KL81 0 0 0 0 0 1 0 0 0 
60 KL124 0 0 1 0 0 0 0 1 0 
61 KL33 0 0 1 0 0 0 0 0 0 
62 KL43 0 0 1 0 0 0 0 0 0 
63 KL50 0 0 1 0 0 0 0 1 0 
 Unk 0 0 24 0 19 4 8 11 18 
K-loci are ordered by highest to lowest mean prevalence across all sites. Note that the Thai site is excluded 
from these calculations due to small sample size (n=4). Unk; unknown. 
 
  





Kong India Laos Nepal Vietnam Mean ESBL+ Carb+ 
O1 67 48 35 69 66 50 56 55 44 
O2 12 26 15 8 16 15 15 13 16 
O1/O2a 0 4 11 0 0 3 3 5 7 
O3b 10 11 6 10 3 9 8 6 4 
O4 2 4 0 2 3 4 2 3 0 
O5 7 4 0 0 0 4 2 1 0 
O3/O3a 0 0 0 8 0 3 2 3 0 
OL101 2 0 0 0 6 1 2 1 0 
OL103 0 4 0 2 0 1 1 1 0 
OL104 0 0 2 0 0 0 0 1 2 
OL102 0 0 0 0 0 1 0 0 0 
Unk 0 0 31 2 6 10 8 12 28 
Predicted O types are ordered by highest to lowest mean prevalence across all sites. Note that the Thai site is 
excluded from these calculations due to small sample size (n=4).  
a It was not possible to confidently distinguish between O1 and O2 for a minority of genomes (n=12 in total). 
The prevalence of these genomes is shown here by site and among ESBL+/Carb+ isolates. These values are 
added at the second position in the cumulative prevalence plot (Figure 2B). Unk; unknown
